Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04881175 · ClinicalTrials.gov registry record · NA
Histological Study on Safety and Efficacy of a RF Device Flexible Applicator for Non-Invasive Lipolysis
A NA study, sponsored by Cynosure.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04881175: Clinical Trial NA study, sponsored by Cynosure.
NCT04881175 is a NA study that was terminated before completion, run by Cynosure. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04881175, a NA study, was terminated before completion, sponsored by Cynosure.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a prospective, open-labeled, non-randomized, multi-center clinical study to collect efficacy data on the TempSure FlexSure applicator for fat lipolysis.
Primary Outcome
Photographs of the histological samples before and after the treatment (only one treatment occurred) will be examined for adipocyte necrosis. Each specimen will first be preserved with a fixative and stained with Hematoxylin and eosin (H\&E stain). To determine whether or not the samples are expressing histological changes, a pathologist will look at the histology of each individual sample and record if they see any changes in histology post treatment vs. the histology taken at the baseline (the
Interventions
- DEVICE Non-Invasive Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2021-02-25 |
| Phase | NA |
Why NCT04881175 stopped before completion
NCT04881175 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Non-Invasive Treatment is the first listed.
NCT04881175 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04881175 about?
NCT04881175 is a clinical study titled "Histological Study on Safety and Efficacy of a RF Device Flexible Applicator for Non-Invasive Lipolysis". This is a prospective, open-labeled, non-randomized, multi-center clinical study to collect efficacy data on the TempSure FlexSure applicator for fat lipolysis.
What is the current status of trial NCT04881175?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2021-02-09. Estimated completion is 2021-02-25.
What interventions are being tested in trial NCT04881175?
The interventions under investigation include: Non-Invasive Treatment (DEVICE).
Who is sponsoring clinical trial NCT04881175?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04881175's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI